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ABSTRACT
Ferroxidase-II was definitely identified as a lipoprotein.
Cholesterol and phospholipids remained tightly associated with the
ferroxidase-II protein following extensive purification. Quantitative
analysis showed that it is a high-density lipoprotein. Thin-layer
chromatographic analyses indicated that phosphatidylcholine accounts
for the majority of the bound phospholipid with lysophosphatidylcholine
and sphingomyelin accounting for the remaining.phospholipid.
Treatment of purified ferroxidase-II with phospholipase C or A
resulted in a loss of ferroxidase activity which paralleled the
hydrolysis of phospholipid.

Phospholipid D treatment also resulted in

the loss of ferroxidase activity, yet the loss was not as great as
with other phospholipases. A lipid-depleted form of ferroxidase-II
was prepared by acetone extraction, or gel-filtration following
treatment with phospholipase C.

However, hydrolysis, not removal, of

the lipid was sufficient for the loss of ferroxidase activity.
Disc-gel electrophoresis and protein elution patterns from gelfiltration columns of the native and lipid-depleted ferroxidase-II
demonstrated that no gross structural changes occur during lipiddepletion. The loss of copper accompanied lipid-depletion. The loss
of copper explained the inactivation of ferroxidase-II occurring on
hydrolysis and removal of lipids.

Reconstitution studies with lipid-

depleted ferroxidase-II indicated that the changes occurring during
hydrolvsis and removal of the lipids were not readily reversible.
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LITERATURE REVIEW
Although copper has been a useful metallic element for thousands
of years, its presence in living matter was not discovered until about
a century and a half ago. The amount required by an organism is
minuscule; the adult human body, for example, contains only about 100
milligrams of copper (1). Yet, it has been found to be involved in
life processes to a surprising extent. Evidently copper, along with
iron and a few other trace metals, became incorporated in living matter
at an early stage in the evolution of life, and it has remained as a
vital trace element ever since.
As with most of the essential transition metals, the importance of
copper arises from the fact that it is a required constituent of numerous
essential proteins and enzymes. Those copper enzymes whose catalytic
functions are well understood are listed in Table I (2).
Copper possesses three chemical properties which account for its
effectiveness as a biological agent (1).
(a) Copper ions react strongly with amino acids or proteins
and consequently form very stable chelates with
biologically active substances.
(b) Copper is an exceptionally effective catalytic agent.
Its catalytic activity may be enhanced and made more
specific when the ion is incorporated in a protein to fonn
a copper enzyme.
(c) Copper's ionization states have flexible properties that
make it particularly suitable for oxidative metabolic
functions.

TABLE I
IMPORTANT COPPER PROTEINS AND ENZYMES
Name

Where Found

mol wt
10 3 gm

Biochemical Function

Cytochrome
oxidase

Most plants and
animals

Hemocyanin

Mollusk and anthro- 450-6,680
pod plasma

Oxygen carrier

Ceruloplasmin

Plasma of most
animals

151

Fe(III)-transferrin
formation, Copper
transport

Amine oxidase

Most animals, etc.

225

Elastin, collagen
, formation

Tyrosinase

Animal skin,
melanoma, insects
plants

35
100

Tyrosine oxidation,
skin pigment
(melanin) formation

Dopamine-13hydroxylase

Adrenals

290

Epinephrine biosynthesis

Ga lactose
oxidase

Molds

75

Galactose oxidation

Erythrocuprein

Red blood cells of
most animals

34

Superoxide dismutase

Ascorbic acid
oxidase

Many plants

150

Terminal oxidase

Plastocyanin

Algae, green leaves
and other plants

70

21

Terminal

oxida~e

Photosynthesis

4

Interest in the biological role of copper has greatly increased as
the recognition of its role in a number of key physiological processes
has developed. These include its importance in elastin and collagen
formation which prevent aneurisms, soft bones, and other defects (3,4).
It is also an important component of cytochrome oxidase, the terminal
oxidase of the electron transport chain of mitochondria (5).

Finally,

copper also appears to serve a vital role in the formation of hemoglobin,
the oxygen carrying protein of blood (6,7,8).
In 1927, Warburg and Krebs observed that mammalian blood sera
possessed a fairly constant copper content (9). Twenty years later,
Holmberg and Laurell demonstrated that at least 90% of normal serum
copper was in the globulin protein fraction and that the increase in
serum copper observed during pregnancy and infections was also associated
with this protein fraction (10).
In 1948, Holmberg and Laurell isolated from mammalian plasma an
intensely blue, copper-containing protein which they named 11 caeruloplasmin 11
(11). They found that this newly identified protein had a molecular
weight of 151,000, contained 8 copper atoms per molecule, and belonged
to the plasma protein class of a-globulin. The a-globulin nature of
ceruloplasmin explained Holmberg and Laurell 's earlier finding that 90%
of the copper of serum was associated with the globulin protein fraction
(10).
Ceruloplasmin has been reported to have oxidase activity in vitro
towards many substrates. Holmberg and Laurell_found oxidase activity with
p-phenylenediamine and several other organic compounds (12). ·During his
investigation of the effects of inorganic ions on the oxidase activity of
purified human ceruloplasmin with N,N-dimethyl-p-phenylenediamine,
Curzon found that the system was very sensitive to metals, both inhibition
and activation were observed (13}.
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The most marked activating effect was found with ferrous iron.
Curzon and O'Reilly's experiments {14) showed that ceruloplasmin was
able to oxidize ferrous to ferric iron and this explained the activating
effect of iron on the ceruloplasmin catalyzed oxidation of a number of
organic compounds. Curzon concluded that any substance which is
oxidizable by ferric iron is potentially oxi-Oizable by the coupled
iron-ceruloplasmin system. The effectiveness of this system and its
ability to compete with a direct ceruloplasmin-substrate interaction
vary widely from substrate to substrate {15). Curzon and Vallet {16)
suggested that the conflicting results in the literature on the activity
of ceruloplasmin against 5-hydroxytryptamine and adrenaline may to some
extent be

explicable in terms of coupled iron-ceruloplasmin oxidation

system.
The recognition of anemia in the copper-deficient animal was
reported in 1928 (6).

In copper-deficient pigs, it was eventually

revealed as a severe anemia, both hypochromic and microcytic {7,18).
Lahey, et ai. (7) compared blood analyses of five-day-old pigs fed a
milk diet supplemented with iron and litter-mate controls on the same
diet supplemented with both iron and copper.

He observed that serum

copper fell rapidly. ·This was followed by a decrease in serum iron,
erythrocyte copper, and eventually by a dramatic reduction in red cell
volume (7).

In copper-deficient rats, Owen and Hazelrig observed a

decrease in plasma ceruloplasmin and copper. The decrease in ceruolplasmin
was followed by a slower but steady decline in liver copper and in
hemoglobin (8).

This led Cartwright, et ai. to pursue the idea of a role

for copper in the biosynthesis of hemoglobin. This role could be effected
at one of the three main lines of hemoglobin biosynthesis:

the biosynthesis

of protoporphyrin or heme, the utilization of iron, or the biosynthesis of

6

globin.

Early hopes to find a copper-dependent step in heme biosynthesis

were abandoned by Lee, et ai. (19). They found that as anemia developed
in copper-deficient swine, there was a 2-3 fold increase in the activity
of heme biosynthetic enzymes, o-aminolevulinic acid synthetase, a-ketoglutaric acid-dependent glycine decarboxylase, and heme synthetase.
They concluded that the anemia of copper def.iciency was not the result
of defective heme biosynthesis and copper was not a co-factor in any of
these reactions. There is also no evidence for any impairment 1n globin
biosynthesis. Thus it seemed most reasonable to assume that copper is
essential for the proper utilization of iron (19).
While a connection between iron and copper metabolism has been
appreciated for over 40 years, no authentic molecular mechanisms had
been proposed until Osaki, et ai. reported on the possible significance
of the ferroxidase activity of ceruloplasmin in nonnal human serum and
proposed that this catalytic activity was involved in promoting the rate
of iron saturation of transferrin in the plasma and in iron utilization
(20,21).

It is generally believed that the iron entering the blood

stream from the intestine or liver storage sites is mostly in the ferrous
form (22).

In the plasma, Fe(II) is rapidly oxidized to Fe(III), and is

incorporated into the specific iron-binding protein, transferrin, which
can bind two atoms of Fe(III) per each protein molecule, forming a red
Fe(III)-protein. When Fe(II) is added to apotransferrin, oxygen is
required for the formation of the red complex, and the rate of color
formation depends on the rate of Fe(II) oxidation to Fe(III) by molecular
oxygen (22).

Koechlin also mentioned that the rate of complex fonnation

between ferrous ion and apotransferrin was enhanced by certain catalytic
factors present in plasma (23).

From Osaki and his coworkers' experiments,

a biological role for ceruloplasmin in iron metabolism may ensue from its
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catalytic activity in converting Fe(II) to Fe(III), thereby promoting
the rate of incorporation of Fe( III) into apotransferrin (20), as
schematically presented below.
ceruloplasmin

Y-

2 Fe(II)

reduced
~
ceruloplasmin
2 Fe(III)

r-

apotransrerr1n

transferrin

The ceruloplasmin-catalyzed rate of Fe(II) oxidation under conditions
that might be expected to prevail in human serum is 10 to 20 times faster
than the nonenzymi c oxidation. The nonenzymi c r·ate would not account for
the daily turnover of iron in the plasma (20).
Any erythroid stimulation leads to a faster turnover of iron in vivo,
and erythroid suppression has the opposite effect (24). Only the reticulocytes are capable of utilizing the Fe(Ill) bound to transferrin, although
both the reticulocytes and matured red cell can take up free Fe(III) •.
Katz and Jandl (24) stated:

11

Thus, transferrin, in some manner, directs

the entry of iron into those cells which are still actively synthesizing
hemoglobin and prevents its presumable needless accumulation by the
matured cell. 11 These facts supported the generally accepted idea that
any Fe(II) absorbed from the intestine or removed from liver storage
sites is oxidized and incorporated into apotransferrin in the plasma, and
transferred to the marrow. Transferrin appears to be the protein which
exclusively supplies iron to the marrow. The availability of iron to the
reticulocytes of the bone marrow can be rate-limiting. The rate of
formation of Fe(lll) from Fe(ll) in plasma and of transferrin formation
could play a significant role in the overall turnover of iron. The fact
that·ceruolplasmin can increase this rate under physical conditions
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suggests that thts ts a possible biological function for ceruloplasmin,
as is schematically shown below (9,20).
H2 0 !?-< 02

Fe(III)-Ferritin

Fe(II)

-e/

~ +e-

ceruloplasmin

Fe(II)--- - --Fe( II

l

reduced
ceruloplasmin

R

I

I

Fe(Ilr:f fe(III)

\iother/

Hemiglobin, etc.

RH

Fe compounds

pot ransferrin

·:
Other
Fe(I I)--.!)Fe
4\
proteins
I
I

'
I

I

GUT

transferri n-...........~e( II I)

MUCOSAL CELLS or
LIVER STORAGE CELLS

PLASMA

BONE MARROW

RH 2 = Ascorbate
R = Dehydroascorbate
Prevailing theory of iron metabolism showing the possible
role of ceruloplasmin promoting iron utilization.
There is now considerable evidence from both in vitro and in vivo
systems which supports the proposal that ceruloplasmin is the key link
between iron and copper metabolism (25,26,27,28,29).

Roeser, et al.

demonstrated that the injection of ceruloplasmin into the blood stream
of copper-deficient pigs resulted in a rapid rise in the plasma iron
concentration (25). This rise in plasma iron concentration was followed
by a gradual rise in the concentration of hemoglobin of the blood stream.
Osaki, et al. perfused livers from copper-deficient pigs with saline
solutions containing ceruloplasmin and observed a rapid mobilization of
stored iron from the liver into the perfusing solution (26,27).

No

mobilization of iron was observed with perfusing solution devoid of
ceruloplasmin.
While the name ceruloplasmin, coined by its discoverers, Holmberg
and Laurell (11), will always retain its historical importance, Osaki,
et al. anticipated that the name

11

Ferroxidase 11 may be more useful than
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designating this enzyme as a sky-blue substance from plasma (20).
One major objection was raised to the idea that ceruloplasmin is
the key link between copper and iron metabolism. This objection arose
from studies of iron metabolism in Hepatolenticular Degeneration, more
conmonly referred to as Wilson's Disease (33).

In this disease the serum

is largely depleted of ceruloplasmin, and then copper diffuses into the
tissues, where it may accumulate to a high level, particularly in the
liver and brain.

It can produce severe mental illness and death.

If

iron metabolism is dependent on ceruloplasmin, we might expect a
disturbance in iron metabolism in Wilson's Disease. However, most
Wilson's Disease subjects investigated were found to have low normal or
normal levels of iron transport (30).

In attempting to correlate the

aryldiamine oxidase activity with the ferroxidase activity of sera from
Wilson's Disease patients, it was observed that these sera had more
ferroxidase than expected (30,31).

Lee, et aZ. (32) proposed citrate

as an alternative source of ferrous iron-oxidizing activity in low
ceruloplasmin serum.

Frieden and Osaki suggested the possibility of an

alternative protein ferroxidase, quite different from ceruloplasmin,
which might substitute for the normal enzyme in Wilson's Disease sera
(30).

In 1970, Topham and Frieden identified, purified, and partially

characterized the alternative protein ferroxidase from normal human
sera and Wilson's Disease sera {33}. They named this non-ceruloplasmin
ferroxidase protein Ferroxidase-II
11

11

•

Ferroxidase-II differed from ceruloplasmin in many respects as
illustrated in Table II{33}.
Three of the most important differences were that Ferroxidase-II:
{a) was yellow rather than blue as ceruloplasmin.
{b} it was not inhibited by azide.
{c) it exhibited no p-phenylenediamine oxidase activity.

10

TABLE II
PROPERTIES DISTINGUISHING FERROXIDASE-11 FROM CERULOPLASMIN
PROPERTY
Inhibition 'with 1
Azide

CERULOPLASMIN
nt'1

>

98%

FERROXIDASE-11
None

Apparent Km values for
Fe( II}

2

1

Specific activity
(A~ 60 per 10 min per
mg of protein}

30

4.9

p-Phenylenediamine oxidase
activity

Yes

None

Elution after chromatographya

.2 to .3 M
NaCl required

No NaCl required

Color of purified preparation

Blue

Yellow

Molecular weight

151,000

>

Copper content (millimicromoles of copper
per mg of protein)

44

12

Inmunoelectrophoretic
migration from origin

Large

Small

Effect of dialysisb

~ 35% remaining

100% activity

activity

800,000

a Adsorption on DEAE-Sephadex; eluted with .05 MAcetate buffer,
pH 5.5, with or without .2 to .3 MNaCl
b Dialysis for 2 days at 4°C against .05 Macetate buffer, pH 5.5
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The ferroxidase-11 protein in human serum, which contributes
appreciably to the rate of Fe(lll}-transferrin formation, was shown to
be a constituent of blood plasma Cohn fraction IV-1 (33).
Topham and Frieden's work indicated that while the ceruloplasmin
level of Wilson's Disease serum decreases very dramatically, ferroxidaseII is less affected. The total ferroxidase activity of Wilson's Disease
sera is approximately 5 ~ 10% of that of normal sera. They found only
about 10% of the total ferroxidase activity of normal sera was necessary
in order to observe maximum iron mobilization responses from liver (33).
Thus, total ferroxidase of Wilson's Disease serum will be enough for
normal or low normal iron metabolism (33,31). However, without
ferroxidase-11 which accounts for 30% of the total ferroxidase in
Wilson's Disease sera, this would not be possible.

Ferroxidase-11

also accounts for the fact that p-phenylenediamine oxidase activity
(another oxidase activity of ceruloplasmin) did not correlate with
ferroxidase activity in Wilson's Disease sera and in sera from some other
animals (26,30,31).
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IHTRODUCTION
From data obtained from gel filtration and disc-gel electrophoresis
(33), it would appear that ferroxidase-II lll.lst have a molecular weight
between 800,000 to 2,000,000 which is lll.lch larger than the value of
151,000 for ceruloplasmin (34). Purified ferroxidase-II was also
subjected to irrmunoelectrophoresis. A single major precipitation arc
was observed when cross-reacted with whole anti-human serum and stained
with buffalo-black (33) or oil red, a stain for lipoproteins (35). The
ferroxidase-11 protein migrated only a small distance toward the anode
and it had a mobility similar to that of serum lipoproteins.

(Cerulo-

plasmin under the same conditions, migrated lll.lch further toward the
anode.)
To date, no one has reported an enzymic function for _a blood lipoprotein. The molecular weight, irrmunoelectrophoretic mobility, and
staining characteristics of ferroxidase-II suggested that lipid components
were tightly bound to the enzyme following extensive purification.
Thus, this thesis sought to investigate the possible lipoprotein
nature of ferroxidase-II. The basic approach was the following:
(1) To establish ouantitatively that lipids were associated
with the enzyme.
(2) To identify the nature of the lipids associated with the
enzyme.
(3) To determine if these lipids were essential to the
maintenance of the catalytic function (ferroxidase activity)
of the enzyme.
(4)

If so, to deterr.tine how these lipids might be involved in
the ciaintenance of catalytic activity.
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(5} To develop methods for preparing a lipid-depleted form
of the enzyme and to attempt to reconstitute the enzyme
by

the addition of specific lipids to the lipid-depleted

form of thP Pnzyme.
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EXPERIMENTAL PROCEDURES
Isolation and Purification of Ferroxidase-II from Human Plasma
Pure ferroxidase-II was prepared from Cohn fraction IV-1 of human
plasma basically as described by Topham and Frieden (33}. This plasma
fraction contains ceruloplasmin (ferroxidase-1} and ferroxidase-11 as
well as other contaminating proteins but contains only 5% of the total
protein of blood plasma. Thus, it represents an excellent starting
material for the purification of ferroxidase-11.

Routinely, five grams

of lyophilized Cohn IV-1 (obtained from the E. R. Squibb and Sons, Inc.,
New York, New York} was extracted with 100 ml of 0.05 Macetate buffer,
pH 5.5, for 4 hours at 4° with gentle continuous stirring. The
resulting extract was centrifuged at 25,000 x gravity, 4° for 30 minutes
to remove any undissolved materials. The supernatant from this centrifugation was passed through a thin layer of fine glass wool to remove the
floating lipid layer and then dialyzed in the cold for 24 hours with 2
liters of 0.05 Macetate buffer, pH 5.5 to remove any small molecular
weight impurities from the Cohn IV-1 extract. The dialyzed Cohn IV-1
extract was recentrifuged at 25,000 x gravity for 30 minutes to remove
any material which precipitated during the dialysis.
Ceruloplasmin {ferroxidase-I} and ferroxidase-II differ greatly in
charge at pH 5.5. At- this pH, ceruloplasmin is highly negatively
charged; however, ferroxidase-II bears little charge. Thus, these two
proteins of human plasma exhibiting ferroxidase activity may be
completely separated by chromatography on an anion exchange resin, DEAEsephadex A-50. The entire dialyzed extract of Cohn IV-1 (100 ml} was
applied to a column {4 cm x 15 cm} of DEAE-sephadex A-50. The column
was washed with 0.05 Macetate buffer, pH 5.5.

Ferroxidase-I (cerulo-

plasmin} remained as a small blue band at the top of the column.
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Ferroxidase-II was eluted from the column with.0.05 Macetate buffer,
pH 5.5. The resulting yellowish eluant containing ferroxidase-II was
concentrated to 30 ml by ultrafiltration in an Amicon ultrafiltration
eel 1.
To further purify ferroxidase-II, the concentrated solution was
applied to a column (4.5 cm x 53 cm) of Agarose A-50 M, a molecular
sieving material for proteins of mol. wt. 10 x 10'+ ';t 50 x 10 6 • Three
bands of protein were eluted from the column with 0.05 Macetate buffer,
pH 5.5. ·The first band was turbid and presumably contained denatured
protein material (33). The second of these bands was clear yellow and
possessed 90% of the ferroxidase-II activity. The third band was
colorless and contained no ferroxidase-II activity. The second band
was collected and concentrated by ultrafiltration to a value of 20 ml
and passed through another Agarose A-50 Mcolumn (3 cm x 45 cm). A
single light yellow protein band possessing ferroxidase-II activity was
eluted from this column.
Method of Assay of Enzymic Activity
Ferroxidase assays were carried out spectrophotometrically measuring
Fe3+_transferrin formation at 460 nm as previously reported (31,33). The
basis of this assay procedure is
(1}

ill~strated

(2)

Fe2+ + Eox -+ Fe3.+ + Ered
Fe 3+ + ApoTf + Fe 3±rf (460 nm)

(3)

Ered + ~2+ E0 x + H20

in the following equations:

Eox =oxidized ferroxidase-II; Ered =reduced ferroxidase-11;
~poTf

= iron-free transferrin. The oxidation of iron by ferroxidase-11

is rate-limiting (28,29}.
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Quartz spectrophotometric cuvets, 1.5 ml in capacity and 1 cm in
path length, contained 0.35 ml of a 0.6 Macetate buffer, pH 6.0; 0.25 ml
of the 2% (w/v) apotransferrin solution; 0.30 ml of the 1 x

10-~

M

ferrous anmonium sulfate solution; 0.10 ml of distilled water, and 0.10
ml of the enzyme preparation. The time course of absorbance change at
460 nm resulting from the formation of transferrin from apotransferrin
and Fe(II) was recorded with a Beckman Acta-III spectrophotometer
equipped with 0.1 absorbance scale. The specific activity was recorded
as

th~

absorbance per 10 minute per mg protein.

(See ''Results")

Quantitative Determination of Protein, Phospholipid, and Cholesterol
Protein concentrations were determined by the method of Lowry (36).
This method combines the use of the biuret and phenol reagents.

In the

biuret reaction, solutions containing protein are made strongly alkaline
with sodium hydroxide and very dilute copper sulfate is added. A
purplish to pinkish violet color is obtained. The phenol reagent
consists of phosphomolybdic and phosphotungstic acids. The final blue
color obtained in the Lowry method depends on a combination of the biuret
reaction and the reduction of the phosphomolybdic-phosphotungstic reagent
by tyrosine and tryptophan present in the protein. This method is rapid,
sensitive (limit of detection, 5 µg/ml; 10 to 20 times more sensitive
than simply measuring the ultraviolet absorption at 280 nm, 100 times
more sensitive than the biuret method), and specific for protein.
Specifically, duplicate standards of 1 ml of a bovine serum albumin
solution (0.2 mg/ml) and a blank containing distilled water were prepared.
~~~

One-tenth ml of solution of unknown protein concentration .were diluted to
1 ml with distilled water.
NaOH; 0.5%

CuSO~;

Five ml of Lowry B solution (2% Na 2 C0 3 ; 0.1 M

1% sodium tartrate) were added to each tube. The tubes
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were mixed and allowed to stand 10 minutes. To each tube was added
0. 5 ml of phenol reagent (Phipps and Bird, RicllTlond, Virginia). Maximum
color developed in l hour, at which time, the absorbance of each tube at
600 nm was recorded.
Lipid phosphorus was determined by Bartlett's method (37). This
method is based on the detennination of
acid digests of the lipid.

inor~anic

phosphate in perchloric

Perchloric acid under reflux rapidly oxidizes

lipids with quantitative release of phosphorus as inorganic phosphate.
The inorganic phosphate is allowed to react with ammonium molybdate to
fonn phosphomolybdic acid, which is reduced and then detennined spectrophotometrically. As little as 0.01 micromole of phosphorus may be
detected. Specifically, samples containing up to 0.15 micromole of
phosphorus were digested for 20 minutes with 0.4 ml of 70 "' 72% perchloric
acid in 18 x 150 mm test tubes. Duplicate standards of 0.3 ml of 0.5 trM
KH2P04 (0.15 micromole of phosphorus) plus 0.4 ml of perchloric acid and
a blank of perchloric acid alone were prepared. After digestion, the
tubes were cooled and 2.4 ml of ammonium molybdate reagent and 2.4 ml of
diluted (1:12, v/v) reducing agent (30 g NaHS0 3 , 6 g Na 2S0 3 , and 0.5 g
1,2,4-aminonapthol sulfonic acid per 250 ml) were added. The samples
were mixed and heated in a boiling water bath for 10 minutes. The tubes
were allowed to cool and the absorbance of each tube was recorded at
830 nm. An average molecular weight (775 g per mole) of phospholipid was
used in the calculation of phospholipid contents.
A simple rapid micro technique described by Zak (38) was used to
detennine cholesterol concentrations. The technique is based on the
precipitation of protein from the sample by the addition of an acetic
acid solution of ferric chloride, leaving the liberated cholesterol in
the supernatant solution. A diluted aliquot of the supernatant solution
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is treated with concentrated sulfuric acid which yields a color that is
stable, reproducible, and obeys Beer's law.over a wide range of analysis
(50 ·µg to 700 µg cholesterol per ml). The colored complex and the
mechanism of its formation are not completely understood at present.
However, the mechanism of the reaction and formation of color does
appear to involve oxidation and dehydration of cholesterol.

Specifically,

the following reagents were prepared:
(a)

Ferric chloride stock reagent:

840 mg of FeCl 3

•

6 H2 0

was dissolved in glacial acetic acid and diluted to 100 ml
with glacial acetic acid.
(b)

Ferric chloride precipitating reagent:

Reagent (a) was

diluted 1:10 (v/v) with glacial acetic acid.
(c)

Ferric chloride blank and diluting reagent: 8.5 ml of
reagent (a) was diluted to 100 ml with glacial acetic acid.

(d) Cholesterol stock standard: 100 mg of pure cholesterol was
dissolved in glacial acetic acid and diluted to 100 ml with
glacial acetic acid.
(e) Cholesterol working standard:

2.5 ml of reagent (d) was

added to 2.1 ml of reagent (a) and diluted to 25 ml with
glacial acetic acid.

(Prepared just prior to performing

the analysis.)
For the preparation of the standard cholesterol curve, 0, 1, 2,
3 ml of reagent (e) were diluted to 4 ml with reagent (c) and O.l ml
of 0.05 Macetate buffer, pH 5.5 was added to each tube. Then, from
each tube, 3 ml of the aliquot was withdrawn and 2 ml of concentrated
sulfuric acid was layered on the liquid surface, mixed well, and
permitted to come to room temperature. The absorbance of each tube at
560 nm was measured. The absorbance vs. concentration was plotted and
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a linear relationship observed.

For the determination of cholesterol

content in ferroxidase-11 preparations, 0.1 ml of the sample was
pipetted into 4 ml of the reagent (b) and mixed well. After 3 minutes,
the mixture was filtered into a test tube. Two ml of concentrated
sulfuric acid was mixed with a 3 ml of the aliquot of the clear yellow
filtrate. The solution was allowed to come to room temperature. The
absorbance was recorded at 560 nm and the cholesterol content was
calculated from the standard curve.
Qualitative Identification of Lipids by Thin-Layer Chromatography
Lipid components were isolated from 2 ml of the pure ferroxidase-11
preparations by overnight extraction with 40 ml of chloroform:methanol
(2:1, v/v). The extracts were washed with 8 ml of distilled water by
the procedure of Folch, et ai. {39). The lipid components were contained
in the chloroform (lower) phase. Separation of the aqueous and chloroform
phases during washing was greatly facilitated by the addition of a small
quantity of solid NaCl. The chloroform phase was concentrated to a
volume of l ml under a stream of N2 •
Individual lipids were separated by thin-layer chromatography. Thinlayer plates coated with silica gel H were purchased from Analtech, Co.,
Inc., Newark, Del.

Plates were activated at least 1 hour at 1100 C

before chromatography {37) •.
{a)

Identification of Individual Phospholipids:
Solutions containing 6 mg/ml of each of the following
standards were prepared in chloroform:methanol {2:1, v/v).
Phosphatidylcholine {PC), lysophosphatidylcholine {LPC},
phosphatidylserine {PS), phosphatidylethanolamine (PE),
sphingomyelin (SPh), cholesterol {C), and cholesterol
acetate {CE). The standards {5

~

10 µl) were applied to
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the plate individually and as a mixture. Samples (50 µl)
of the lipid extracts of ferroxidase-II were also applied
to the plate. Chloroform:methanol:acetic acid:water
(25:15:4:2, v/v) was used as the developing solvent. To
detect lipid spots following development, the plates were
allowed to dry and then placed in a tank saturated with
iodine vapor. Lipids appeared as intense brown spots in
the iodine vapor.
(b)

Identification of Individual Neutral Lipids:
Solutions containing 6 mg/ml of each of the following
neutral lipids were prepared in chloroform:methanol (2:1,
v/v) cholesterol (C), cholesterol acetate (CE), monoglyceride
(monopalmitin, MG), 1,2-diglyceride (1,2-dipalmitin, 1,2-DG},
1,3-diglyceride (l,3-dipalmitin, 1,3-DG), triglyceride
(tripalmitin, TG), free fatty acid (palmitic acid, FA).
The standards (10 µl) were applied to the plate, individually
and as a mixture. Samples of the lipid extract of ferroxidaseII were also applied. Hexane:diethylether:acetic acid (20:80:1,
v/v) was the developing solvent.

Following development, the

plates were allowed to dry, sprayed with 50% sulfuric acid,
and placed in an oven at 1800 C for at least 2 hours. The
sulfuric acid charred the lipids which then appeared as
intense black spots.
Treatment of Ferroxidase-II with Phospholipases
Phospholipase A Treatments: These treatments were performed as described
by Topham and Gaylor (40). Thirty-five µl of a phospholipase A solution
(from Vipera russeZZi, 2 mg protein/ml, 7.7 units/mg protein; one unit
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will hydrolyze 1 µmole of L-a-Lecithin to lysolecithin and a fatty acid
per min., pH 6.5, at 37°), 0.5 ml of a 0.4 MCaC1 2 solution, and 2 ml of
a purified ferroxidase-II preparation were incubated at 30° with gentle
shaking for various time intervals. Controls containing 0.5 ml of 0.4 M
CaCl2, 2 ml of purified ferroxidase-II, and 35 µl of 0.05 Macetate buffer,
pH 5.5, instead of phospholipase A were incubated at 30°. The ferroxidase
activity of each sample as well as the control and the extraction and
separation of the individual phospholipids from each sample were carried
out as previously described.
Phospholipase C Treatments: These treatments were perfonned according to
the procedure reported by Topham and Gaylor (40). Two ml of purified
ferroxidase-II, 0.02 ml of 0.4 MCaC1 2, and 0.5 mg of phospholipase C
(10 units/mg, l unit liberates 1.0 µmo·le of water-soluble organic
phosphate from egg yolk lecithin per minute) were incubated at 30° with
gentle shaking for various time intervals.

Controls containing purified

ferroxidase, CaC1 2, but no phospholipase C was incubated at 30°. The
ferroxidase activities of the samples and of the controls were determined,
the lipids extracted and washed, and the lipid phosphorus contents
detennined as previously described.
Phospholipase D Treatments: Two ml of purified enzyme, 0.02 ml of 0.4 M
CaC1 2, and 100 µl of a

pho~pholipase

D solution (1 mg protein/ml) were

incubated at 300 for various time intervals. Controls containing all
components but 100 µl of 0.05 Macetate buffer, pH 5.5, instead of 100 µl
phospholipase D were incubated at 300. The ferroxidase activities of the
samples and of the controls were determined, the lipids were extracted
and washed, and the individual phospholipids separated as previously
described.
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Attempt to Prepare a Lipid-Depleted Enzyme by Acetone Extraction
A modified 'form of the procedure of Moore and Gaylor was used (41).
Ten ml of the purified enzyme was added in dropwise manner to 30 ml of
prechilled (-15°) acetone, stirred for 30 minutes and the temperature
maintained at -15°.

Instead of the filtration procedure suggested by

Moore and Gaylor (41), centrifugation was used to harvest the protein
precipitated by the acetone.

The acetone-layer was decanted. A second

30 ml ·portion of prechilled acetone was added to the

~esidue,

stirred

and centrifugated. The acetone-layer again was decanted. The resulting
powder was dried under a gentle stream of N2 , dessicated and stored in a
vial, and kept in the freezer until used.
The acetone powder (3.8 mg) was dissolved in 1 ml of 0.05 Macetate
buffer, pH 5.5, and the ferroxidase activity and the phospholipid per mg
protein were determined.
Attempt to Prelare Lipid-Depleted Enzyme by Phospholipase Treatment
Followed by Ge -Filtration
(a) Phospholipase A Treatment and Gel-Filtration:
Four ml of the purified ferroxidase-II were treated with
phospholipase A for 2 hours as previously described.

Following

treatment, 2 ml of the preparation was subjected to gelfiltration on a column (0.9 x 12 cm) of Sephadex G-100.
The protein was eluted from the Sephadex G-100 with 0.05 M
acetate buffer, pH 5.5. The fractions from the column
containing protein were combined. The ferroxidase activity,
protein concentration, and phospholipid content of the
preparation were determined as previously described, prior
to the treatment with phospholipase A and following treatment
with phospholipase A and gel-filtration on sephadex columns.
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Controls containing all components except phospholipase A
were carried through the same procedure.
(b) Phospholipase C Treatment and Gel-Filtration:
Thirty ml of purified ferroxidase-II, 0.3 ml of 0.4 MCaC1 2 ,
and 3.8 mg of phospholipase C were incubated for two hours
at 30°. Following the incubation, a 20 ml sample of the
treated material was applied to a column (3 x 45 cm) of
Agarose A-50 M (a gel-filtration material with a greater
capacity and larger fractionation range than the sephadex
gels). The eluting solvent was 0.05 M acetate buffer,
pH 5.5.

Eighty 5.5 ml fractions were collected utilizing

a Gilson Model 80 micro-fractionator. The protein
concentration of every other fraction was determined as
previously described. Two protein bands were eluted from
the column. The fractions composing each of these separate
bands were combined, concentrated by ultrafiltration, and
the ferroxidase activity, protein concentration, phospholipid
content and cholesterol content determined as previously
described. A sample of purified ferroxidase-II which had
not been treated with phospholipase C was applied to the
same Agarose A-50 Mcolumn and subjected to gel-filtration
in an identical manner to the treated sample.
Disc-Gel Electrophoresis
Disc-gel electrophoresis was performed by the simplified procedure
described by Davis (42). Standard,uniform bore,straight glass tubes
(120 mm x 4 mm) were filled with a 4% polyacrylamide separating gel to
a height of 60 mm, and layered with 0.025 MTris-glycine buffer, pH 8.8.
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Sufficient solid sucrose was added to the ferroxidase-II preparations
to obtain a 5% sucrose solution. Twenty-five

~l

of the dense sucrose-

ferroxidase-II solution was carefully allowed to drop through the buffer
solution to the top of the separating gel. The gels were subjected to
5 ma per gel at pH 8.8, 0.025 Mtris-glycine buffer for 35 minutes.
After electrophoresis the gels were stained.with Coomassie Blue, a
protein stain, as described by Chrambach, et aZ. (43).
Copper Determination
Copper contents of ferroxidase-II preparations were determined by
the method of Wharton and Rader (44). This method involves the treatment
of a protein solution with glacial acetic acid to liberate bound copper,
reduction of the copper with mercaptoacetic acid, chelation of Cu(I) by
bathocuproine (4,7-diphenyl-1,10-phenanthroline), precipitation of the
protein with 95% ethanol, and removal of the precipitated Cu-free protein
by centrifugation. The Cu(I)-bathocuproine complex is colored and the
intensity of the color is directly proportional to the Cu concentration
in the range of 5 to 70 nanomoles of Cu per ml. Specifically, 0.4 ml
of the appropriate ferroxidase-II solution, 0.1 ml of a 5% (w/v) solution
of mercaptoacetic acid, 0.5 ml of 0.1% (w/v) solution of bathocuproine
in glacial acetic acid,
5 minutes.

o.5

ml of 95% ethanol were mixed vigorously for

Blanks containing 0.4 ml of 0.05 M acetate buffer, pH 5.5

instead of the ferroxidase-II solution were prepared in the same manner.
A standard curve was prepared with samples containing 10, 25, 50 and 100
nanomoles of Cu and this standard curve used for the calculation of Cu
contents of various ferroxidase-II preparations. All samples were read
at 479 nm.
Reconstitution
Attempts were made to reconstitute the enzymic activity of lipid-

25

depleted ferroxidase-11 prepared by acetone extraction or phospholipase
C treatment followed by gel-filtration.
The lipid-depleted enzyme from acetone extraction (3.8 mg) was
dissolved in 1 ml of 0.05 Macetate buffer, pH 5.5. To 0.35 ml of this
solution was added 0.1 mg of phosphatidylcholine to reestablish the
phospholipid to protein ratio present in the preparation before lipiddepletion. The solution was incubated for 2 hours at 300.

Following

incubation, the specific activity of the solution was detennined.
Two tenths ml of a glycerol solution of phosphatidylcholine (l.68
mg/ml) was added to 2 ml of the lipid-depleted enzyme prepared by
phospholipase C treatment followed by gel-filtration. This quantityof phosphatidylcholine was equivalent to the phospholipid present in the enzyme
preparation prior to lipid-depletion. The resulting solution was
incubated for 2 hours at 30°.

Following incubation, the solution was

dialyzed overnight with 0.05 Macetate buffer, pH 5.5, to remove any
non-protein bound phosphatidylcholine. The phospholipid content, protein
content, and specific activity of the dialyzed preparation were determined.
A control containing 2 ml of the lipid-depleted enzyme, 0.2 ml of pure
glycerol, but no phosphatidylcholine was incubated and dialyzed in an
identical manner. The specjfic activity of the contrcl was detennined.
The addition of this quantity of pure glycerol did not significantly
affect the activity of the enzyme.
Reconstitution was also attempted by the addition of phosphatidylcholine and cholesterol and by the addition of phosphatidylcholine,
cholesterol, and copper to the lipid~depleted enzyme. Two mg of
phosphatidylcholine and 1 mg of cholesterol were suspended in 1 ml of
0.05 Macetate buffer, pH 5.5 by gentle homogenization. To 1 ml of the
lipid-depleted enzyme (prepared by phospholipase C treatment and gel-
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filtration) was added 0.15 ml of the lipid suspension to reestablish
the phospholipid and cholesterol contents present before lipid depletion.
To another 1 ml sample of the lipid-depleted enzyme was added 0.3 ml of
the lipid suspension to yield twice the phospholipid and cholesterol
contents present before lipid-depletion.
for 2 hours at 300.

Both samples were incubated

Following incubation, the specific activity of each

sample was determined.
Two mg of phosphatidylcholine and 1 mg of cholesterol were dissolved
in glycerol.

The previous experiment was repeated with the glycerol

solution of lipid replacing the buffer suspension of lipid.
In a third experiment, 0.15 ml and 0.3 ml of the buffer solution of
phosphatidylcholine and cholesterol were added to 1 ml samples of the
lipid-depleted enzyme preparation. One tenth ml of a CuS0 4 solution {500
µmoles of Cu/ml) was added to the sample containing 0.15 ml of the
buffer suspension of lipids and 1 ml of the lipid-depleted enzyme
preparation. Two tenths ml of the CuS0 4 solution was added to the
sample containing 0.3 ml of the buffer suspension of lipids and l ml of
the lipid-depleted enzyme
for 2 hours at 30°.

preparation~

These samples were incubated

Following incubation the specific activity of each

sample was determined.
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RESULTS
Quantitative Determination of Lipids Bound to Ferroxidase-II
The molecular

w~ight,

immunoelectrophoretic mobility, and staining

properties reported for Ferroxidase-II by Topham and Frieden (33)
suggested that this serum enzyme might be a lipoprotein. Most of the
lipid bound to blood serum lipoproteins is in the form of the neutral
lipid, cholesterol, and the polar phospholipids (46}. Thus, the phospholipid and cholesterol contents of six separately purified ferroxidase-II
preparations of high specific activity were determined. The ferroxidase11 preparations contained lipid both in the form of cholesterol and
phospholipid. All six preparations had a consistent ratio of protein,
phospholipid, and cholesterol (Table l}. The purification procedure for
ferroxidase-II involves extensive dialysis, ion-exchange chromatography,
ultrafiltration, and gel-filtration which should result in the loss of
any unbound or loosely bound lipids from the ferroxidase-II preparations.
Thus, these lipid components must be tightly associated with the purified
enzyme.
Qualitative Identification of Individual Phospholipid and Neutral Lipids
Thin-layer chromatographic analyses were carried out to ascertain
which individual phospholipids and neutral lipids were bound to
ferroxidase-II.

Phosphatidylcholine accounts for the majority of the

bound phospholipid with small amounts of sphingomyelin and lysophosphatidylcholine accounting for the remaining phospholipid (Figure l}.
Cholesterol, its esters, and other neutral lipids move with the solvent
front in this particular developing solvent system (chloroform:methanol:
acetic acid:water - 25:15:4:2, v/v). Therefore, in order to identify
the neutral lipid components a second solvent system (hexane:diethyl
ether:acetic acid= 20:80:1, v/v) was employed. Spots for cholesterol,

TABLE 1
Quantitative Determination of Lipids Bound to Ferroxidase-II
'

Enzyme
Preparation
No.

Specific Activity

Protein

Phospholipid

Cholesterol

(A 460 nm/10 min/mg protein)

(mg/m1)

(mg/m1)

(mg/m1)

Phospho1ipid:
Cholesterol:
Protein

1

2.79

4.65

±

.02

0.72

±

.005

0.47

±

.06

l .5:1 :10

2

2.03

4.70

±

.05

0.60

±

.03

0.34

±

.01

1.3:0.7:10

3

3.31

7.40

±

.02

0.92

±

.03

0.72

±

.03

L3:1:10

4

4.72

3.72

±

.02

0.43

±

.002

0.38

±

.04

1.2:1 :10

5

3.79

3.82

±

.02

0.56

±

.01

0.45

±

.03

1.4:1.2:10

6

2.87

5.11

±

.03

0.68

±

.003

0.53

±

.004

1.4:1.1:10

N
(X)
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FIGURE 1
Qualitative Identification of Individual Phospholipid of Ferroxidase-11
Thin-layer chromatographic analyses were carried out as described
in "Experimental Procedures".

The developing solvent system was

CHC1 3 :CH30H:CH 3COOH:H20 (25:15:4:2, v/v).
1-1. Rf of standards------- C(.989); PE(.659); PS(.512);
PC(.182); Sph(.122); LPC(.089).
Rf of sample------- Spot #1(.989); Spot 12(.234);
Spot #3(.124); Spot 64(.077).
1-2. Rf of standards ------- CE(.976); C(.935); PE(.574);
PS(.475); PC(.418); Sph(.344); LPC(.230).
Rf of sample -------Spot 11(.984); Spot 12(.916);
Spot #3(.457); Spot #4(.356); Spot #5(.272).
C = Cholesterol
CE

= Cholesterol

LPC

= Lysophosphatidylcholine
= Phosphatidylcholine
= Phosphatidylethanolamine
= Phosphatidylserine

PC
PE
PS

Sph

acetate

=Sphingomyelin

fE
fS

1-1

1-2
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cholesterol esters, and fatty acids were obtained with this solvent
system (Figure 2}.
Treatment of Ferroxidase-II with Phospholipases
Several enzymes attached to the inner membrane of the mitochondria
of the cell, appear to have an absolute requirement for specific phospholipids for the maintenance of enzymic activity (47).

It would be quite

interesting if the enzymic activity of ferroxidase-II, a blood serum
1ipoprotein, exhibited a similar requirement. Toc:Etermine whether the
phospholipids bound to ferroxidase-II were essential for the maintenance
of enzymic activity, purified ferroxidase-II preparations were treated
with phospholipases, enzymes normally manufactured in the pancreas which
catalyze the hydrolysis of phospholipids.

Phospholipase A, C, and D, each

catalyze the hydrolysis of phospholipid at a specific but different
position as illustrated below:
(a)· Phospholipase A hydrolysis:
0

0

II

II -

-->-~ ~-C-0

R-C-O-CH2

+

0

II

R'-C-0-CH

I

0

·11

+

CH 2 -0-~-0CH2CH2N{CH3)3

6-

phosphatidy1cho1ine
(b)

fatty acyl group

lysophosphatidylcholine

Phospholipase C hydrolysis:
0

II

R-C-O-CH2

phosphatidylcholine

0

II
---> R-C-O-CH2

+

1,2-diglyceride

phosphocholine
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FIGURE 2
Qualitative Identification of Individual Neutral Lipids of Ferroxidase-11
Thin-layer chromatographic analyses were carried out as described
in "Experimental Procedures". The developing solvent system was
hexane:diethylether:acetic acid (20:80:1, v/v).
2-1.

Rf of standards ------- TG(.932); CE(.831); FA(.729);
l,3-DG(.712); l,2-DG(.644); C(.526); MG(.237).
Rf of sample------- Spot #1(.864); Spot #2(.757);
Spot #3(.7); Spot #4(.522).

2-2.

Rf of standards------- TG(.825); CE(.736); FA(.640);
l,3-DG(.632); l,2-DG(.552); C(.474); MG(.123).
Rf of sample------- Spot #1(.745); Spot #2(670);
Spot #3(632); Spot #4(.482).

C = Cholesterol
CE = Cholesterol acetate
1,2-DG=1,2-dipalmitin (1,2-diglyceride)
1,3-DG = 1,3-dipalmitin (1,3-diglyceride)
FA

= Palmitic

acid {free fatty acid)

MG = Monopalmitin (monoglyceride)
TG = Tripalmitin (triglyceride)

2-1

2 -2
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(c)

Phospholipase D hydrolysis:
0

0

II

1

I~ I

R-C-0-CH

I

+

- - > R-C-0-CH 2 + HOCH 2CH 2N(CH 3 ) 3

R- Lo-CH2

1

0

~

I

R-C-0-CH

II

+
CH-0-1-0-CH 2CH 2N(CH 3 ) 3

I

0

II _

CH2-0-P-O ·

ophosphatidylcholine

phosphatidic acid

choline

Phospholipase C hydrolysis of phosphatidylcholine results in the
formation of a 1 ,2-diglyceride and water-soluble phosphocholine. Thus,
phospholipid hydrolysis could be monitored simply by following the
disappearance of lipid bound phosphorus from chloroform:methanol extracts
of treated ferroxidase-II preparations. Treatment of purified ferroxidaseII with phospholipase C resulted in a progressive loss of ferroxidase
activity which paralleled the hydrolysis of phospholipid (Figure 3-1 and
3-2).

In the first 10 minutes of treatment, the activity and phospho-

lipid content decreased dramatically; little change in activity or phospholipid content was observed after 1 hour of treatment.

No ferroxidase

activity was lost from the control samples incubated without phospholipase
C. The loss in activity and hydrolysis of phospholipid following 80
minutes of treatment were compared for several ferroxidase-II preparations
(Table 2).

The loss of activity and hydrolysis of phospholipid were

comparable for all four preparations examined.
Treatment of purified ferroxidase-II with phospholipase A also
resulted in the progressive loss of ferroxidase activity (Figure 4).
The activity declined dramatically during the first 10 minutes of treatment.

No loss in ferroxidase activity was observed in the control flasks

without phospholipase A.

Phospholipase A hydrolysis of phosphatidylcholine
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FIGURE 3-1 and 3-2
Time Course of Loss of Ferroxidase Activity and Hydrolysis of Phospholipid
of Ferroxidase-II with Phospholipase C
The phospholipase C treatment of ferroxidase-II was carried out
as described in "Experimental Procedures".

Ferroxidase activities and

phospholipid contents of ferroxidase-II were determined at several time
intervals.
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TABLE 2
Comparison of Loss of Activity and Phospholipid Hydrolysis with Phospholipase C Treatment
for Several Ferroxidase-II Preparations
Enzyme
Preparation
No.

Specific
Activity

7

3.17

8

3.31 '

9

2.79

.10

2.03

Time of
Treatment
(min)

Activity
(A4 6onm!lO min)

Phospholipid
(mg/ml)
j_ ..HYcfr.o.l'lS.is_

..%..To_s_s_

-

0.47 ± .002

-

71

0.14 ± .004

70

1.30

-

0.67 ± .003

-

80

0.36

72

0 .15 ± .001

78

0

o. 91

-

0.48 ± .005

-

80

0 .17

82

0 .10 ± • 003

77

0

0.95

-

0.43 ± .005

-

80

0.29

70

0.09 ± .005

80

0

1.34

80

0.38

0

w

co
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FIGURE 4
Time Course of Loss of Ferroxidase Activity of Ferroxidase-11 with
Phospholipase A
The phospholipase A treatment of ferroxidase-11 was carried out
as described ·in "Experimental Procedures". The ferroxidase activity
of the samples was determined at several time intervals·.
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results in the formation of lysophosphatidylcholine and a fatty acyl
group.· Thus, phospholipid hydrolysis could not be monitored simply
by following the disappearance of lipid phosphorus in the chloroform:
methanol extracts of treated samples. Phospholipid hydrolysis was
monitored by thin-layer chromatography.

Disappearance of the spot for

phosphatidylcholine and intensification of the spot for lysophosphatidylcholine was observed on thin-layer chromatography of the lipid extracts
from treated samples (Figure 5). The loss of ferroxidase activity
following 2 hours treatment with phospholipase A was compared for
several different ferroxidase-II preparations (Table 3). The loss in
activity was comparable with all preparations tested.
Treatment of purified ferroxidase-II with phospholipase D also
resulted in the loss of activity (Figure 6). However, the extent of
inactivation at similar time intervals was not nearly as great as
observed in treatment with phospholipase C or A. Hydrolysis of
phosphatidylcholine with phospholipase D results in the formation of
phosphatidic acid and choline. Thus, phospholipid hydrolysis could
not be monitored simply by following the disappearance of lipid phosphorus
in the chloroform:methanol extracts of treated samples.

Phospholipid

hydrolysis was monitored by thin-layer chromatography (Figure 7).
Little decrease in the intensity of the spot for phosphatidylcholine
was observed suggesting that phospholipase D was not nearly as effective
for the hydrolysis of the phospholipids bound to ferroxidase-II as
phospholipase C or A. The extent of inactivation after 40 minutes
treatment with phospholipase D was determined for two separate
ferroxidase-II preparations. The loss of activity was comparable for
the two preparations (Table 4).
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FIGURE 5
Thin-Layer Chromatography of Phospholipids of Ferroxidase-11 Before
and After Phospholipase A Treatment
The extracted samples after phospholipase A treatment were applied
to thin-layer chromatographic plates as described in "Experimental
Procedures".
On the plate:
Column #1: Mixture of standards were applied C, CE, PE, PS, PC,
Sph, LPC.
Column #2, #3: Extracted sample of purified ferroxidase-11.
PC was the most intense spot.
Column #4, #5, #6, #7, #8: Lipid extracts after 10, 20, 40, 80,
160 minutes of phospholipase A treatment.
Column #9:

Spots of standard PC and LPC.

TABLE 3
Comparison of Loss of Activity with Phospholipase A Treatment
for Several Ferroxidase-II Preparations
Enzyme
· Preparation
No.

Specific
Activity

7

3.17

8

3.31

9

4.72

Time of
Treatment
(hrs)

Activity
(A 46 anm11 o min) .

%Loss of
Activity

0

1.39

-

2

0.48

66

0

1.03

-

2

0.44

58

0

1.03

-

2

0.36

65

.i::=.
.p.
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FIGURE 6
Time Course of Loss of Ferroxidase Activity with Phospholipase D
Treatment
The phospholipase D treatment of ferroxidase-II was carried out
as described in "Experimental Procedures". The ferroxidase activities
of treated samples were determined at several time intervals.
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FIGURE 7
Thin-Layer Chromatographic Analysis of Phospholipids of Ferroxidase-11
Before and After Phospholipase D Treatment
The extracted samples after phospholipase D treatment were subjected
to thin-layer chromatographic analysis as described in "Experimental
Procedures".
On the plate:
Column #1: Mixture of standards (C, CE, PE, PS, PC, Sph, LPC
and phosphatidic acid}.
Column #2-#7:

Extracted samples of phospholipase D treatment

of ferroxidase-11 after 10, 20, 40, 60, 80, 160
minutes.
Column #8:

Spot of standard phosphatidic acid.

TABLE 4
Comparison of Loss of Activity with Phospholipase D Treatment
for Several Ferroxidase-II Preparations
Enzyme
Preparation
No.

Specific
Activity

8

3.31

9

4.72

Time of
Treatment
(min)

Activity

% Loss of
Activity

0

0.984

-

40

0.672

32

0

1.10

-

40

0.55

35

~

\C
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Attempts to Prepare A Lipid-Depleted Form of Ferroxidase
The loss of activity observed when ferroxidase-II preparations
were treated with phospholipases, particularly phospholipase C or A,
indicated that intact phospholipids were essential for the maintenance
of maximum enzymic activity.

It was felt that the preparation of a

lipid-depleted form of the enzyme might provide clues regarding the
specific role that phospholipids serve for ferroxidase-11.

Furthermore,

if a lipid-depleted form of the enzyme could be successfully prepared,
it might be possible to reconstitute the enzymic activity by the
addition of specific lipids and thus to establish which individual
lipids were most essential.
Frequently, lipids have been dissociated from lipoproteins simply
by extraction with acetone at ice temperature (-15°). The acetone
extraction, if successful, results in the removal of lipids and the
precipitation of the protein without significant denaturation. Acetone
extractions of purified ferroxidase-11 preparations resulted in the
formation of a very finely divided precipitate which could not easily
be isolated by filtration.

The precipitate was collected by centrifu-

gation; however, the precipitate represented less than 10% by weight
of the protein originally present in the preparation before acetone
extraction. A portion of the powder obtained was redissolved in 0.05 M
acetate buffer, pH 5.5, and the protein content, phospholipid content,
and the specific activity were determined (Table 5). The phospholipid
to protein ratio decreased dramatically

indic~ting

that considerable

phospholipid had been removed during the acetone extraction; however,
the acetone extract had little ferroxidase activity. A sample of the
powder obtained during acetone extraction was saved for reconstitution
experiments to be discussed later.

TABLE 5
Acetone Extraction of Ferroxidase-II
Treatment

Specific Activity
(A4sonm/lO min/mg protein)

None

3.77

Redissolved
Acetone
Extract

0.14

-

Protein
(mg/ml)

Phospholipid
(mg/ml)

PhosEholiEid
Protein

3.82 ± .02

0.56 ± .01

0.15

1.45 ± .05

0.04 ± .001

0.03

<.11
__,
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Because of the poor yield obtained during acetone extraction,
other methods for the preparation of a lipid-depleted form of the
enzyme were sought. The intact phospholipids bound to ferroxidase-II
were not removed by the gel-filtration techniques employed during the
purification of ferroxidase-II. As previously described, the treatment
of purified ferroxidase-II with phospholipase A or C resulted in the
formation of hydrolysis products of the bound phospholipids.

It seemed

possible that these hydrolysis products might be more easily removed.
from ferroxidase-II than intact phospholipids.· Thus, the preparation of
a lipid-depleted form of the enzyme was attempted by subjecting phospholipase A or C treated ferroxidase-II to gel-filtration. The loss of
phospholipid hydrolysis products was monitored by the determination of
total phosphorus (lipid and non-lipid phosphorus in the ferroxidase-II
preparation before treatment and after treatment and gel-filtration)
(See Bartlett Method; "Experimental Procedures").

It was felt that the

phospholipase treatment and gel-filtration represented a milder procedure
in terms of protein denaturation than subjecting the enzyme to organic
solvent extraction.
Ferroxidase-II preparations were treated with phospholipase A for
2 hours and applied to a column of Sephadex G-100. A11 ·fractions
collected from the column containing protein were pooled. The protein
content, phospholipid content, and specific activity of the pooled
sample were determined. As observed in previous experiments, phospholipase A treatment resulted in a dramatic decrease in the specific
activity of the ferroxidase-II preparation, but the phospholipid:protein
ratio following gel-filtration was only decreased by 24% (Table 6). This
indicated that the majority of the hydrolysis products of the phospho1ipids remained bound to the enzyme following gel-filtration.

TABLE 6
Lipid-Depletion of Ferroxidase-11 by Phospholipase A Treatment
Followed by Gel-Filtration
Treatment

Specific Activity
(A460nm/10 min/mg protein)

Protein
(mg/ml)

Phospholipid
(mg/ml)

PhosEholiEid
Protein

%Loss of
Phospholipid

None

2.53

3.76 ± .03

0.74 ± .004

0 .198

-

Treatment with
Phospholipase A
for 2 hrs.
followed by
gel-filtration

0.51

1.57 ± • 02

0.24 ± .004

Q.153

24

01

. (Al
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Similar experiments were performed with phospholipase C. A
purified ferroxidase-II preparation was treated 2 hours with phospho1ipase C and then subjected to gel-filtration on a column of Agarose
A-50 M.

Following gel-filtration, all column fractions containing

protein were pooled and the protein content, phospholipid content, and
specific activity of the pooled sample were determined. The specific
activity of the preparation following phospholipase C treatment and gelfiltration was drastically reduced. The phospholipid:protein ratio was
reduced by 87% indicating that the majority of the phospholipid originally
bound to the ferroxidase-II protein had been removed (Table 7).

It was

possible that the loss of the bound phospholipid following hydrolysis
with phospholipase C and gel-filtration might be accompanied by a loss
of bound cholesterol. Thus, the experiment was repeated with a second
purified ferroxidase-II preparation and the cholesterol:protein ratio
in addition to the phospholipid:protein ratio was determined before
treatment and after phospholipase C treatment and gel-filtration
(Table 8). The phospholipid:protein ratio was reduced by 83% which
compared well to 87% observed with the first preparation. The
cholesterol:protein ratio was also markedly reduced indicating that
indeed bound cholesterol as well as phospholipid had been removed from
the ferroxidase-II protein. The hydrolysis of phospholipids by phospholipase C results in the formation of a 1,2-diglyceride and phosphocholine.
Thus, a spot for 1,2-diglyceride should appear on thin-layer chromatography of a lipid extract of phospholipase C treated samples before
gel-filtration.

Following gel-filtration this spot should disappear if

indeed the phospholipid hydrolysis products are being removed during
the gel-filtration procedure. The appearance of a spot for 1,2-diglyceride
was observed in lipid extracts of phospholipase C treated samples prior to

TABLE 7
Lipid-Depletions of Ferroxidase-II by Phospholipase C Treatment
Followed by Gel-Filtration
Treatment

Specific Activity
(A460nm/10 min/mg protein)

PhosEholiEid
Protein

None

2.97

0.15

2 hrs. with
Phospholipase C
followed by
Agarose A-50 M
gel-filtration

0.09

0.020

%Loss of
Phospholipid
Based on Protein

87

01
01

TABLE 8
Lipid-Depletion of Ferroxidase-11 by Phospholipase C Treatment
Followed by Gel-Filtration
Treatment

None
2 hrs. with
Phospholipase C
followed by
Agarose A-50 M
gel-filtration

Specific Activity
Phos_Q.holi~id/Protein
ratio
i Loss
{A 460 nm/10 min/mg protein)

Chol esterol_LProtein
ratio
~ Loss

1.73

0.12

-

0.08

-

0

0.02

83

0.03

63

01
O"I
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gel-filtration. This spot was not observed with lipid-extracts of
phospholipase C treated samples following gel-filtration (Figure 8).
Investigations Concerning Possible Structural Changes and Loss of
Copper During Lipid-Depletion
.
The treatment of ferroxidase-II with phospholipase C followed by
gel-filtration provided a method for the preparation of a lipid-depleted
form of the enzyme in high yield. The removal of bound lipid could
possibly alter the structure of ferroxiqase-II and this alteration in
structure could result in the loss of

activity~

To determine if any

large change in the structure of ferroxidase-II had occurred during
lipid depletion, the elution patterns of the native and lipid-depleted
ferroxidase-II protein from an Agarose A-50 Mcolumn were compared.
The elution patterns for native and lipid-depleted ferroxidase-II were
extremely similar (Figure 9). However, with the lipid-depleted
ferroxidase-II preparation a very small turbid band of protein (< 15%
of the total protein) was eluted prior to the major protein band. This
minor band could represent a small amount of denatured protein which
may have been formed during the gel-filtration or incubation procedures.
The major protein band obtained with the lipid-depleted sample had an
elution volume identical to that of the native enzyme.. This would
indicate that no gross changes in the three-dimensional shape of the
protein occurred during the lipid-depletion procedure. Native and
lipid-depleted ferroxidase-II were also subjected to disc-gel electrophoresis (a technique which separates proteins in the basis of size,
shape, and charge simultaneously). The electrophoretic mobilities of
the native and lipid-depleted enzyme were identical (Figure 10). The
electrophoretic results also indicated that no gross

chang~

in the three-

dimensional shaoe had occurred during the lipid-depletion procedure.
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FIGURE 8
Neutral Lipid Components of Ferroxidase-II Before and After LipidDepletion

by

Phospholipase C Treatment and Gel-Filtration

Thin-layer chromatographic analyses were carried out as described
in "Experimental Procedures". The developing solvent system was
hexane:diethylether:acetic acid (20:80:1, v/v).
8-1.

Rf's of standards ------- TG(.932); CE(.831); FA(.729);
l,3-DG(.712); l,2-DG(.644); C(.526); MG(.237)
Rf's of extracted ferroxidase-11

~------Spot

#1(.894);

Spot #2(.787); Spot #3(7); Spot #4(.532).
Rf's of extracted sample after phospholipase C treatment
followed by gel-filtration------- Spot #1(.816);
Spot #2(.702); Spot #3(.64); Spot #4(.517).
8-2.

Rf's of standards ------- TG(.825); CE(.736); FA(.64);
l,3-DG(.632); l,2-DG(.552); C(.474); MG(.123).
Rf's of extracted ferroxidase-11 (enzyme) ------Spot #1(.799); Spot #2(.745); Spot #3(.632); Spot #4
(.482).
Rf's of extracted sample of ferroxidase-II after
phospholipase C treatment (ECT) -------Spot #1(.702);
Spot #2(.526); Spot #3(.456).
Rf's of extracted sample of ferroxidase-II after
phospholipase C treatment followed by gel-filtration
(1) Band a (ECTA-50 Ba) -------Spot #1(.768)
(2) Band b (ECTA-50 Bb) -------Spot #1(.797);
Spot #2(.655}; Spot #3(.584); Spot #4(.469).

8-1

8- 2
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FIGURE 9
Comparison of Protein Elution Patterns for Native and Lipid-Depleted
Ferroxidase-II
The protein elution patterns of gel-filtration of native and
lipid-depleted ferroxidase-II were determined as described in
"Experimental Procedures".
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FIGURE 10
Comparison of Electrophoretic Mobilities of the Native and Lipid-Depleted
Enzyme Preparations
Disc-gel electrophoresis was performed as described in "Experimental
Procedures". The electrophoretic mobilities of native and lipid-depleted
ferroxidase-II were compared.
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Copper remains tightly associated with ferroxidase-II following
purification (33) and this copper associated with ferroxidase-II has
been shown to be essential for its ferroxidase activity (48}. The
removal of lipid components from ferroxidase-II might in some manner
effect the afinity of the enzyme for copper. Thus, the copper content,
phospholipid content, cholesterol content, and specific activity before
and after lipid-depletion were compared for a purified ferroxidase-II
preparation. As expected from previous experiments, a dramatic loss
in the phospholipid and cholesterol bound to the ferroxidase-II was
observed following phospholipase C treatment and gel-filtration. A
dramatic loss of bound copper accompanied the loss of the lipid
components (Table 9).
Reconstitution Attempts
A dramatic decrease in the specific activity of purified
ferroxidase~II

preparations was observed when bound phospholipids were

hydrolyzed by phospholipase treatment or removed by acetone extraction
or phospholipase C treatment followed by gel-filtration. This indicated
that the lipid must be essential for the maintenance of the catalytic
activity of ferroxidase-II.

Reconstitution experiments were performed

to attempt to restore the activity of the lipid-depleted enzyme by the
addition of specific lipids or specific lipids and copper.
The addition of phosphatidylcholine to the acetone extracted enzyme
did not result in a significant reconstitution of ferroxidase activity
(Table 10). The addition of phosphatidylcholine to ferroxidase-II
depleted of lipid by phospholipase C and gel-filtration also did not
result in a significant reconstitution of the ferroxidase activity
(Table 11).

Furthermore, little phosphatidylcholine appeared to bind

the lipid-depleted enzyme.

TABLE 9
Lipid and Copper Depletion of Ferroxidase-II by Phospholipase C Treatment
Followed by Gel-Filtration
Specific Activity
(A460nm110 min/mg protein)

Treatment

None
Agarose A-50
MGelfiltration
after phospholipase
C treat·ment

PhosEholiEid
Protein

Cholesterol
Protein

Copper Content
(nanomoles/mg protein}

2.59

0.15

0.09

10.29

0

0

0

0

0.08

0.05

0.03

0.54

B

A
N1
D
B

A2
N
D

en

U1

TABLE 10
Addition of Phosphatidylcholine to Acetone-Extracted Ferroxidase-II
Treatment

Activity
(A 460 nm/10 min)

Protein
(mg/ml)

Specific Activity
(A 460 nm/10 min/mg protein}

Recovery of
Specific Activity

None

1.42

3.82

±

.02

3.77

-

Following
acetone
extraction

0.02

1.45

±

.01

0.14

-

Reconstitution
after acetone
extraction

0.05

l .45

± • 01

0.34

. 9.0%

°'
°'

TABLE 11
Addition of Phosphatidylcholine to Lipid-Depleted Ferroxidase-II

Treatment

Percentage of
the original
S_Q_eci fi c Acti.vi tr

PhosEholiEid
Protein

Specific Activity
{A 46 anm/10 min/mg protein)

None

0.17

2.36

100%

2 hrs. with
Phospholipase C
followed by
gel-filtration

0.07

0.25

10.6%

2 hrs. of
incubation of
lipid-depleted
enzyme with
phosphatidylcholine in
glycerol
solution

o. 10

0.08

3.4%

......
°'
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The treatment of ferroxidase-11 with phospholipase C followed by
gel-filtration resulted in the loss of cholesterol and copper as well
as phospholipid. Thus, it was felt that better reconstitution might
be achieved by including cholesterol and copper in the reconstitution
medium.

However, neither the addition of cholesterol nor copper

improved the recovery of ferroxidase activity (Table 12). These·
results suggested that the removal of the lipids from ferroxidase-II
promoted a change in the enzyme which prevented the rebinding of
exogeneously added lipids or copper.

TABLE 12

Addition of Phosphatidylcholine, Cholesterol, and Copper to

Lipid-~epleted

Ferroxidase-II

Specific Activity
Percentage of the
Original
(A460nm/10 min/mg protein)
S_2.ecific Activity_

Treatment

None

2.59

100%

2 hrs. with Phospholipase C Treatment
followed by Agarose A-50 Mgel-filtration

0.08

3. 1%

2 hrs. incubation of lipid
and copper depleted enzyme
with acetate buffer suspension of phosphatidylcholine and cholesterol -

0.00

-

0 .11

4.2%

0.00

-

0.11

4.2%

0.00

-

2 hrs. incubation of lipid
and copper depleted enzyme
with glycerol solution of
phosphatidylcholine and
cholesterol
2 hrs. incubation of lipid
and copper depleted enzyme
with acetate buffer suspension of phosphatidylcholine, cholesterol, and
copper

Adding back to the
original ratio of
phospholipid, and
cholesterol to
protein
Adding back twice
the original ratio
Adding back to the
original ratio of
phospholipid, and
cholesterol to
m-otein
Adding back twice
the original ratio
Adding back to the
original ratio of
phospholipid,
cholesterol, and
cop_p_er to protein
Adding back twice
the original ratio

O'I
l.O

0.15

5.8%
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DISCUSS IO~
It was recognized many years ago that there was a close relationship between lipids and proteins in many natural sources.

In fact, many

proteins appear to complex lipid co:r.ponents very strongly. As data
accumulated on the chemical nature of these cor.:plexes, now tenned
lipoproteins, it was evident that the linkage was not of a covalent but
rather of an associated type. Many type associations, based on the
different polarity regions of lipids and proteins arc possible. Honpolar groups in the side chains of the amino acids of the protein

r.~y

fonn hydrophobic bonds with the long saturated or unsaturated carbon
chains of the triglyceride, fatty acids, phospholipfds or sterols.
Polar groups in the amino acid side chains r..ay also hydrogen bond groups
of similar polarity, particularly the hydroxy functional groups present
in sterols and phospholipids. The negatively charged phosphate groups
present in the phospholipid may also form strong ionic bonds with
positively charged amino groups present in

th~

side chain of tha basic

amino acids of the protein.
To date, the COlilplcte detailed three

df~nsional

structure of a

single lipoprotcin has not yet been detennined. However, the lipoproteins
from blood have received considerable attention. These studies have shown
that there are several different types of lipoproteins and that these

r~y

be categorized conveniently on the basis of their density (46). The lawdensity lipoproteins contain approxinately

eo:

by weight of lipid and

20: by weight of protein. The low-density lipoproteins contain large
quantities of bound triglycerides, cholesterol (or its esters), but
quantities of bound phospholipids.
proteins contain greater than

so:

~all

In contrast, the high-density lipoby weight of protein and less than

bv weiqht of lipid. The high-density lipoprotcins contain large

so:
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quantities of bound phospholipid and cholesterol (or its esters) but
very small quantities of bound triglycerides.
Topham and Frieden's work (33) indicated that ferroxidase-II .could
possibly be a serum lipoprotein. The present study definitely establishes
the lipoprotein nature of ferroxidase-II.

Ferroxidase-II was found to be

approximately 80% by weight of protein and 20% by weight of lipid.
Phospholipid and cholesterol (or its esters) accounted for most of the
lipid of ferroxidase-II.

Phosphatidylcholine constituted the majority

of the phospholipid and lysophosphatidylcholine and sphingomyelin
accounted for the remaining phospholipid. The relative quantities of
lipids and protein and the predominance of phospholipids and cholesterol
would place ferroxidase-II in the high-density class of blood serum
l i poprote ins.
The lipoprotein nature of ferroxidase-II is quite interesting from
another point of view.

It represents the discovery of the first example

of a serum lipoprotein that possesses an enzymic activity.

Furthermore,

intact phospholipids appear to be essential for maintenance of enzymic
activity.

Hydrolysis of the phospholipid with either phospholipase A

or C resulted in a loss of activity which paralleled the hydrolysis of
phospholipid. Treatment with phospholipase D resulted irt some loss of
activity but the loss was not nearly as.complete as observed with
phospholipase A or C. The larger size.of phospholipase D may prevent
it from coming in contact with the majority of the phospholipid bound to
ferroxidase-II and thus account for the much lower degree of inactivation
and phospholipid hydrolysis.

Phospholipases A and C hydrolyze phospha-

tidylcholine at different but at specific positions. The nature of the
hydrolysis products is also quite different. Hydrolysis with phospho1ipase A results in the loss ·of a non-polar fatty acyl group at the 2
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position with the formation of lysophosphatidylcholine (See 11 Results 11 ) .
In contrast, hydrolysis with phospholipase C results in the loss of
phosphocholine, the polar head group, with the formation of a 1,2diglyceride. The hydrolysis of either the non-polar tail or the polar
head group was sufficient for the loss of activity which would suggest
that no single structural feature of the pho5pholipid is solely important
for the maintenance of enzymic activity.

Rather, it would appear that

both polar and non-polar groups may be involved.
The lipid components could be removed from ferroxidase-II by acetone
extraction or phospholipase C treatment followed by gel-filtration.
However, hydrolysis not removal of the phospholipid components was
sufficient for loss of ferroxidase activity.
The loss of ferroxidase activity upon hydrolysis of the phospholipid
associated with ferroxidase-II could be explained in several ways. The
phospholipid could be important for the maintenance of the native structure
of ferroxidase-II and hydrolysis of the bound phospholipid could result
in an alteration in the three dimensional structures which would result
in inactivation of ferroxidase-II.

However, the elution pattern of

native and lipid-depleted ferroxidase-II from gel-filtration columns
were very similar. The mobilities of the nature and lipid-depleted
ferroxidase-II upon disc-gel electrophoresis, a technique for the
simultaneous separation of proteins on' the basis of size and charge, were
also similar. These results would suggest that no gross changes in the
three dimensional shape of ferroxidase-II occurred following hydrolysis
and removal of the bound phospholipid.

However, small subtle changes in

the structure of ferroxidase-II following hydrolysis and removal of lipids
can not be ruled out. To detect small structural changes would require
the crystallization of both native and lipid-depleted ferroxidase-II
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and x-ray crystallographic analyses of both. The crystallization of
ferroxidase-II, in fact .of any lipoprotein, has not yet been achieved.
Even if crystalline ferroxidase-II were available, its very large.
molecular weight would make an x-ray analyses quite complex.

Furthermore,

considerable uncertainty concerning the fair comparison of crystalline
and solution structures for native and lipid-depleted ferroxidase-II
would still exist.
Another possible explanation of the loss of activity following the
hydrolysis of phospholipid was explored. The hydrolysis and loss of the
bound lipids could be accompanied by a loss of copper from ferroxidaseII. In vivo and in vitro studies have shown that copper plays a
functional role in the catalytic activity of ferroxidase-II (48). The
hydrolysis and removal of the bound lipid of ferroxidase-II was
accompanied by the loss of copper. The hydrolysis of the phospholipids
could cause a subtle change in the structure of ferroxidase-II which
would, in turn, reduce the affinity of ferroxidase-II for copper. The
reduction of the affinity of ferroxidase-II for copper could result
from the movement of groups in the protein {possibly side-chain amino
or sulfur groups) so that they are no longer in the proper alignment
for forming a strong ligand complex with copper.

It is also possible

that the polar groups of the phospholipids (the oxygen of the phosphate
group, the nitrogen of the choline group) could be directly involved in
binding of copper to the enzyme. The hydrolysis of phospholipids could
weaken the ability of the groups to participate in cooperation with the
groups in the protein in the binding of copper. The exact manner in
which the lipid, copper, and protein are associated with one another has
not been ascertained.

However, these studies would indicate that the

association among them is indispensable to the catalytic function of
ferroxidase-II.
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Attempts to reconstitute the lipid-depleted form of ferroxidase-II
by the addition of phosphatidylcholine; phosphatidylcholine and cholesterol;
and phosphatidylcholine, cholesterol, and copper resulted in little
regeneration of ferroxidase activity.

This suggests that any structural

change and change in affinity for copper occurring during hydrolysis and
removal of bound lipid are not readily reversible.
Ceruloplasmin and ferroxidase-II have been found in the sera of all
animals investigated to date and these proteins are the sole source of
ferroxidase activity in these animal sera. A detailed comparison of
some of the chemical properties of these two proteins was made in tabular
form in the "Literature Review".

However, it is interesting to compare

these proteins from a slightly different point of view.
contain extremely tightly bound copper atoms.

Both proteins

In addition, ceruloplasmin

contains some bound carbohydrate residues and is thus classified as a
glycoprotein.

Cartwright, et aZ. (25) demonstrated from in vivo studies

that the loss of these carbohydrate residues resulted in a loss in the
ability of ceruloplasmin to mobilize iron from liver storage cells.

In

contrast, ferroxidase-II contains no bound carbohydrate residues but it
contains bound lipid components and is thus considered a lipoprotein.
The studies described in this thesis have demonstrated that the lipid
components of ferroxidase-II are essential for the maintenance of its
ferroxidase activity. Cartwright, et aZ. (25) have suggested that
possibly the carbohydrate residues of ceruloplasmin may in some manner
promote the specific binding of some of the circulating ceruloplasmin
to the surface of the liver storage cell. This bound ceruloplasmin
would be ideally located for promoting the oxidation of any Fe(II)
passing from the liver storage cell into the blood stream.

It is possible

that the lipid components of ferroxidase-II could promote the specific
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binding of ferroxidase-II to the surface of the liver storage cell.
This appears particularly feasible because the membrane composing the
liver cell surface is rich in phospholipids and cholesterol. Thus,
the liver cell membrane represents a hydrophobic environment which
could bind the hydrophobic-lipid rich region of ferroxidase-II.
Verification of this, however, must await further experimentation.
In summary, ferroxidase-II represents a very interesting and
complex enzyme.

It not only contains tightly bound copper but also

tightly bound lipid components and both appear essential for the
maintenance of the catalytic and physiological function of the enzyme.

lb
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